Sirolimus Tablet, Film Coated
Product Images NDC 0904-7248

2 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sirolimus (NDC 0904-7248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (1bef7d8f 524b 4218 8fef 6c3f3628d33e 00)

Carton Label (1bef7d8f 524b 4218 8fef 6c3f3628d33e 00)
Sirolimus 1 mg film-coated tablets label from Major Pharmaceuticals. The label indicates a unit dose of 30 tablets, oral use only, and prescription (Rx) only status. It includes storage instructions, pharmacist dispensing guidance, and manufacturer details, along with the National Drug Code (NDC) 0904-7248-04.*
FDA Label Image

Siro01 (Siro01)

Siro01 (Siro01)
Chemical structure of sirolimus, depicting its molecular arrangement including multiple ring systems, functional groups, and stereochemical bonds, consistent with the active ingredient of the Sirolimus 1 mg oral tablet by Major Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.